Citius Pharmaceuticals Ownership | Who Owns Citius Pharmaceuticals?


OverviewFinancialsChart

Citius Pharmaceuticals Ownership Summary


Citius Pharmaceuticals is owned by 13.33% institutional investors, 6.81% insiders, and 79.86% retail investors. Armistice capital is the largest institutional shareholder, holding 6.38% of CTXR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.29% of its assets in Citius Pharmaceuticals shares.

CTXR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCitius Pharmaceuticals13.33%6.81%79.86%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital10.16M6.38%$5.93M
Vanguard group6.33M3.98%$3.69M
Millennium management2.05M1.29%$1.20M
Blackrock1.81M1.14%$1.05M
Geode capital management1.65M1.03%$961.17K
Goldman sachs group1.19M0.75%$692.60K
Northern trust1.06M0.66%$615.83K
Advisor group932.33K0.59%$544.07K
Susquehanna group, llp640.54K0.40%$373.88K
State street581.80K0.37%$339.60K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Armistice capital10.16M0.07%$5.93M
Point72 asia (singapore) pte.201.88K0.02%$117.83K
Wealth advisory solutions151.00K0.02%$88.14K
Inspire advisors158.24K0.01%$92.37K
Keynote financial services17.50K0.01%$10.21K
Horst & graben wealth management75.72K0.01%$44.20K
Fairscale capital9.15K0.01%$7.78K
Arkadios wealth advisors150.00K0.01%$87.56K
Miller investment management, lp50.00K0.00%$29.18K
Advisor group932.33K0.00%$544.07K

Top Buyers

HolderShares% AssetsChange
Armistice capital10.16M0.07%10.16M
Millennium management2.05M0.00%2.05M
Goldman sachs group1.19M0.00%1.10M
Susquehanna group, llp640.54K0.00%629.32K
Jane street group383.53K0.00%305.08K

Top Sellers

HolderShares% AssetsChange
Blackrock1.81M--6.92M
State street581.80K--1.63M
Geode capital management1.65M0.00%-1.30M
Vanguard group6.33M0.00%-677.86K
Nuveen asset management---484.65K

New Positions

HolderShares% AssetsChangeValue
Armistice capital10.16M0.07%10.16M$5.93M
Millennium management2.05M0.00%2.05M$1.20M
Qube research230.97K0.00%230.97K$134.82K
Point72 asia (singapore) pte.201.88K0.02%201.88K$117.83K
Cubist systematic strategies117.75K0.00%117.75K$68.73K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-18.00
Farther finance advisors-80.00
Pnc financial services group-177.00
Creative financial designs inc /adv-250.00
New york state common retirement fund-1.13K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202455-21.43%23,175,356-23.61%133.66%12-62.50%2538.89%
Jun 30, 202470-2.78%30,339,56412.37%196.61%3214.29%18-21.74%
Mar 31, 202472-4.00%26,999,7700.67%165.97%28-24.32%2391.67%
Dec 31, 202375-1.32%26,820,0007.67%166.43%3732.14%12-36.84%
Sep 30, 202376-2.56%24,909,141-1.58%165.41%28-39.13%1935.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.14M2.29%-
Vanguard Institutional Extnd Mkt Idx Tr1.96M1.08%-
Fidelity Extended Market Index971.13K0.54%-11.10K
NT R2000 Index Fund - NL316.31K0.17%-58.09K
NT R2000 Value Index Fund - NL279.80K0.15%-55.32K
Fidelity Total Market Index259.29K0.14%-637.00
NT R2000 Index Fund - DC - NL - 2250.30K0.14%-47.02K
Northern Trust Russell 2000 Value Index249.69K0.14%6.16K
NT R2000 Value Index Fund - L249.69K0.14%6.16K
BlackRock Extended Equity Market K230.77K0.13%-98.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$1.72M
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$2.00M
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$500.00K
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$430.12K
Apr 03, 2019Mazur Leonard L Executive ChairmanBuy$1.80M

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q1--

CTXR Ownership FAQ


Who Owns Citius Pharmaceuticals?

Citius Pharmaceuticals shareholders are primarily institutional investors at 13.33%, followed by 6.81% insiders and 79.86% retail investors. The average institutional ownership in Citius Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Citius Pharmaceuticals falls below.

Who owns the most shares of Citius Pharmaceuticals?

Citius Pharmaceuticals’s largest shareholders are Armistice capital (10.16M shares, 6.38%), Vanguard group (6.33M shares, 3.98%), and Millennium management (2.05M shares, 1.29%). Together, they hold 11.65% of Citius Pharmaceuticals’s total shares outstanding.

Does Blackrock own Citius Pharmaceuticals?

Yes, BlackRock owns 1.14% of Citius Pharmaceuticals, totaling 1.81M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.05M$. In the last quarter, BlackRock decreased its holdings by -6.921M shares, a -79.31% change.

Who is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Armistice capital is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.07% of its assets in 10.16M Citius Pharmaceuticals shares, valued at 5.93M$.

Who is the top mutual fund holder of Citius Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Citius Pharmaceuticals shares, with 2.29% of its total shares outstanding invested in 4.14M Citius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools